These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30004658)

  • 1. [Current Status of Middle East Respiratory Syndrome Vaccines].
    Fan Y; Jiang Z; Li P; Den Y; Huang J; Zhu L; Xu Z
    Bing Du Xue Bao; 2016 Nov; 32(6):825-9. PubMed ID: 30004658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
    Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
    Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel Research Progress of the Recombinant Vaccine for MERS-CoV].
    Hu H; Shen Y
    Bing Du Xue Bao; 2016 Jul; 32(4):495-500. PubMed ID: 29995374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-binding domain-based subunit vaccines against MERS-CoV.
    Zhang N; Tang J; Lu L; Jiang S; Du L
    Virus Res; 2015 Apr; 202():151-9. PubMed ID: 25445336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.
    Alharbi NK
    Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 27786402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Middle East respiratory syndrome: current status and future prospects for vaccine development.
    Du L; Jiang S
    Expert Opin Biol Ther; 2015; 15(11):1647-51. PubMed ID: 26414077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for the prevention against the threat of MERS-CoV.
    Du L; Tai W; Zhou Y; Jiang S
    Expert Rev Vaccines; 2016 Sep; 15(9):1123-34. PubMed ID: 26985862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice].
    Lan J; Lu S; Deng Y; Wen B; Chen H; Wang W; Tan W
    Bing Du Xue Bao; 2016 Jan; 32(1):77-81. PubMed ID: 27295887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.
    Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM
    Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INFECTIOUS DISEASE. Camel vaccine offers hope to stop MERS.
    Kupferschmidt K
    Science; 2015 Dec; 350(6267):1453. PubMed ID: 26680169
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
    Cho H; Excler JL; Kim JH; Yoon IK
    Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
    Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
    Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.
    Choi J; Kim MG; Oh YK; Kim YB
    Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
    Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
    J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.
    Guo X; Deng Y; Chen H; Lan J; Wang W; Zou X; Hung T; Lu Z; Tan W
    Immunology; 2015 Aug; 145(4):476-84. PubMed ID: 25762305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward a vaccine for Middle-Eastern respiratory syndrome.
    Woodland DL
    Viral Immunol; 2014 Dec; 27(10):483. PubMed ID: 25479177
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies.
    Zhang N; Shang J; Li C; Zhou K; Du L
    Expert Rev Vaccines; 2020 Sep; 19(9):817-829. PubMed ID: 32842811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.
    Zhang N; Channappanavar R; Ma C; Wang L; Tang J; Garron T; Tao X; Tasneem S; Lu L; Tseng CT; Zhou Y; Perlman S; Jiang S; Du L
    Cell Mol Immunol; 2016 Mar; 13(2):180-90. PubMed ID: 25640653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
    Gutiérrez-Álvarez J; Honrubia JM; Sanz-Bravo A; González-Miranda E; Fernández-Delgado R; Rejas MT; Zúñiga S; Sola I; Enjuanes L
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34686605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.